Polar Power Targeting Q1 2024 Rollout for New Line of Mobile Electric Vehicle Chargers
(24/7 MARKET NEWS) – Polar Power Inc. (NASDAQ: POLA) announced, after yesterday’s market close, that it’s now taking advance orders...
Market Movers
Jaguar Health Following through on AI-powered Web Portal Launch Announcement
(24/7 MARKET NEWS) – Jaguar Health, Inc. (NASDAQ: JAGX) announced, before yesterday’s market open, that it launched an artificial intelligence-powered...
Top Premarket Momos for 10 May 2023
(24/7 MARKET NEWS) – This morning’s top premarket momentum gainers include; Unique Fabricating (NASDAQ: UFAB) $0.51 (+182.49%) 26.85M Versus Systems...
IRC Recommends Continuing Addex ADX71149 Phase 2 Epilepsy Clinical Study
(24/7 MARKET NEWS) – Addex Therapeutics (NASDAQ: ADXN) reported, that morning, that the ADX71149 (JNJ-40411813) Phase 2 epilepsy clinical study...
Assertio Hits New 52-Week High after Reporting Q1 2023 Financial Results and Raising 2023 Outlook
(24/7 MARKET NEWS) – Assertio Holdings, Inc. (NASDAQ: ASRT) reported, this morning, its financial results for the first quarter ended...
TScan Therapeutics to Collaborate with Amgen to Identify Novel Targets in Crohn’s Disease
(24/7 MARKET NEWS) – TScan Therapeutics, Inc. (NASDAQ: TCRX) and Amgen (NASDAQ: AMGN) announced, this morning, a multi-year collaboration that...
Ensysce Biosciences Completes Successful Overdose Protection Study
(24/7 MARKET NEWS) – Ensysce Biosciences, Inc. (NASDAQ: ENSC) reported, this morning, that it completed its clinical study of PF614-MPAR-101,...
ClearOne Declares a Special One-time $1 Cash Dividend
(24/7 MARKET NEWS) – ClearOne (NASDAQ: CLRO) announced, yesterday evening, that its Board of Directors has declared a special one-time...
FDA Grants Orphan Drug Designation to Synlogic for SYNB1934 for Treatment of Phenylketonuria
(24/7 MARKET NEWS) – Synlogic, Inc. (NASDAQ: SYBX) announced, this morning, that the U.S. Food and Drug Administration (FDA) granted...
Top Premarket Momos for 8 May 2023
(24/7 MARKET NEWS) – This morning’s top premarket momentum gainers include; Bellicum Pharmaceuticals (NASDAQ: BLCM) $1.15 +0.75 (+187.49%) 21.47M EzFill...
Acorda Therapeutics and Chance Pharmaceuticals Agree to Commercialize INBRIJA in China
(24/7 MARKET NEWS) – Acorda Therapeutics, Inc. (NASDAQ: ACOR) and Hangzhou Chance Pharmaceuticals Co. Ltd. Stated, this morning, that they...
Trevena’s OLINVYK Receives Chinese Approval
Update- 9 May 2023 9 a.m. EDT- This morning’s attempt by the shorters to hammer the price down in the...
FDA Removes Clinical Hold on Immuron’s New Campylobacter ETEC Therapeutic Paves way for Clinical Trial Initiation
(24/7 MARKET NEWS) – Immuron Limited (NASDAQ: IMRN) stated that the US Naval Medical Research Center (NMRC) received US Food...
Top Premarket Momos for 5 May 2023
(24/7 MARKET NEWS) – This morning’s top premarket momentum gainers include; PacWest Bancorp (NASDAQ: PACW) $4.31 +1.14 (+35.96%) 6.88M AGBA...
SMX preparing Legal Investigation into Possible Illegal Shorting and Spoofing
(24/7 MARKET NEWS) – SMX (Security Matters) plc (NASDAQ: SMX; SMXWW) stated, this morning, that Seiden Law has joined SMX's...
Star Equity Holdings Sold Digirad Health for $40 Million
(24/7 MARKET NEWS) – Star Equity Holdings, Inc. (NASDAQ: STRR) announced, this morning, that it completed the sale of Digirad...
Aditxt Subsidiary Signs Clinical Trial Agreement Mayo Clinic to Study Stiff Person Syndrome
(24/7 MARKET NEWS) – Aditxt, Inc. (NASDAQ: ADTX) announced, this morning, that Adimune, its subsidiary, signed a clinical trial agreement...
NANOBIOTIX Enters Final Contract Negotiations for Development and Commercialization of NBTXR3
(24/7 MARKET NEWS) – NANOBIOTIX (NASDAQ: NBTX) stated, this morning, that the Company is entering into final contract negotiations after...
Carvana Reports Increased Total Gross Profit Per Unit and Highest Q1 Adjusted EBITDA in Company History
(24/7 MARKET NEWS) – Carvana Co. (NASDAQ: CVNA) reported, after yesterday’s market close, its financial results for the quarter ended...
Top Premarket Momos for 4 May 2023
(24/7 MARKET NEWS) – This morning’s top premarket momentum gainers include; Altamira Therapeutics (NASDAQ: CYTO) $1.23 +0.375 +43.84% 11.01M Gaucho...
SaverOne Concludes Successful ITC Pilot Demonstration
(24/7 MARKET NEWS) – SaverOne 2014 Ltd. (NASDAQ: SVRE) stated, this morning, that it successfully concluded a pilot demonstration with...
SAB Biotherapeutics Presents Positive SAB-176 Influenza Immunotherapy at ISIRV-AVG Conference
(24/7 MARKET NEWS) – SAB Biotherapeutics (NASDAQ: SABS) stated, this morning, that it presented positive safety and efficacy data from...
Soligenix Reports Positive Compatibility Study Results for HyBryte
(24/7 MARKET NEWS) – Soligenix, Inc. (NASDAQ: SNGX) announced, this morning, positive clinical results from a compatibility study evaluating HyBryte...
Top Premarket Momos for 3 May 2023
(24/7 MARKET NEWS) – This morning’s top premarket momentum gainers include; Kuke Music Holding KUKE 1.06 (+29.32%) 1.25M CNS Pharma...
ImmunoGen Doubles on ELAHERE Phase 3 MIRASOL Trial Announcement
(24/7 MARKET NEWS) – ImmunoGen Inc. (NASDAQ: IMGM) announced, this morning, positive top-line data from the Phase 3 confirmatory MIRASOL...
Aptorum Group Hits New 2023 High
(24/7 MARKET NEWS) – Aptorum Group Ltd. (NASDAQ: APM) had news on Monday and seems to finally be moving much...
Akili Reports Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Video Game-Based Therapeutic Clinical Trial
(24/7 MARKET NEWS) – Akili Inc (NASDAQ: AKLI) reported, this morning, topline results of the STARS-ADHD-Adult clinical trial evaluating the...
Akanda Higher in this Morning’s Premarket Following Yesterday’s Halo Collective Share Issuance Update
(24/7 MARKET NEWS) – Halo Collective Inc. (NASDAQ: HALO), Akanda’s (NASDAQ: AKAN) largest shareholder, provided a disclosure update regarding recent...
Minim Popping
(24/7 MARKET NEWS) – Minim Inc. (NASDAQ: MINM) just started running on no news and trading at $5.30, up $3.28...
Top Premarket Gainers for 2 May 2023
(24/7 MARKET NEWS) – This morning’s top premarket gainers include; Meten Edtechx Educ. (NASDAQ: METX) $0.2602 +0.0432 (+19.91%) 7.94M Huize...
Immatics Reports Interim Clinical Data for Ongoing Phase 1b ACTengine IMA203 TCR-T Trail
(24/7 MARKET NEWS) – Immatics N.V. (NASDAQ: IMTX) announced, this morning, interim clinical data update for 11 patients with recurrent...
KWESST Awarded Five Year Software Systems Development Contract for Canadian Department of National Defence valued at Approximately $20M
(24/7 MARKET NEWS) – KWESST Micro Systems Inc. (NASDAQ: KWE) reported, this morning, that it received notification of contract award...
NeuroBo Pharmaceuticals Receives FDA Clearance for a Phase 2a Clinical Trial of DA-1241 for the Treatment of NASH
(24/7 MARKET NEWS) – NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) stated, this morning, that the U.S. Food and Drug Administration (FDA)...
Lilium Raising $100-250 Million
(24/7 MARKET NEWS) – Lilium N.V. (NASDAQ: LILM) stated, this morning, that it’s closing a funding valued at up to...
Eledon Pharmaceuticals Secures up to $185 M to Advance Tegoprubart Kidney Transplantation Clinical Trials
(24/7 MARKET NEWS) – Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) announced, this morning, that it entered into a private placement that...
Marker Therapeutics Enters Comprehensive Non-Dilutive Agreement with CellReady
(24/7 MARKET NEWS) – Marker Therapeutics, Inc. (NASDAQ: MRKR) stated, this morning, that it entered into a comprehensive agreement with...
Nanox Receives FDA Clearance for its Imaging System
(24/7 MARKET NEWS) – NANO-X IMAGING LTD (NASDAQ: NNOX) announced, this morning, that it received a 510(k) clearance from the...
Minerva Neurosciences Files NDA for Roluperidone for the Treatment of Negative Symptoms in Schizophrenia
(24/7 MARKET NEWS) – Minerva Neurosciences, Inc. (NASDAQ: NERV) announced, this morning, that the U.S. Food and Drug Administration (FDA)...
Top Premarket Gainers for 28 April 2023
(24/7 MARKET NEWS) – Due to technical difficulties, this may be our only post of the day. This morning’s top...
Aytu BioPharma Receives Manufacturing Site Transfer Approval from FDA
(24/7 MARKET NEWS) – Aytu BioPharma, Inc. (NASDAQ: AYTU) stated, this morning, that it received U.S. Food & Drug Administration...